Abametapir
Head lice and their eggs both depend on metalloproteinase enzymes for survival and hatching, and abametapir inhibits those enzymes. That dual activity is the practical advantage of the topical solution: a single application kills live lice and unhatched ova, so the nit-combing conventionally needed to remove viable eggs becomes unnecessary. The preparation is applied to the scalp and hair and acts locally at the site of application, with minimal systemic absorption, and it is approved for adults and children from six months of age. Targeting an enzyme class rather than the insect nervous system also separates it from the neurotoxic pediculicides. The compound is C12H12N2, roughly 184.2 g/mol.
A topical solution applied to the scalp and hair to treat head lice infestations in adults and children aged six months and older. It works by inhibiting enzymes that lice and their eggs need to survive, killing both live lice and unhatched eggs in a single application. The product is left on the hair for ten minutes and then rinsed off, with no nit-combing required afterward.
분자량
184.2400 g/mol
LogP
2.20
TPSA
25.80 Ų
리핀스키 5의 법칙
통과
치료 영역
작용 기전
A metalloproteinase inhibitor. Abametapir inhibits louse metalloproteinases required for egg development and hatching, so ova exposed to it fail to produce viable nymphs.
Pharmacokinetics (PK)
Pharmacodynamics (PD)
A metalloproteinase inhibitor. Abametapir inhibits louse metalloproteinases required for egg development and hatching, so ova exposed to it fail to produce viable nymphs.
2D 구조
Cite this structure
Embed this structure
SMILES
Cc1ccc(-c2ccc(C)cn2)nc1
InChI
InChI=1S/C12H12N2/c1-9-3-5-11(13-7-9)12-6-4-10(2)8-14-12/h3-8H,1-2H3
Molecular Formula
C12H12N2
HBD / HBA
- / 2
회전 가능 결합
1
무거운 원자
14
No targets recorded
Target interaction data is not yet available for this drug.
No interactions recorded
Drug interaction data is not yet available for this compound.
No side effects recorded
Side effect data is not yet available for this drug.
자주 묻는 질문
A topical solution applied to the scalp and hair to treat head lice infestations in adults and children aged six months and older. It works by inhibiting enzymes that lice and their eggs need to survive, killing both live lice and unhatched eggs in a single application. The product is left on the hair for ten minutes and then rinsed off, with no nit-combing required afterward.
A metalloproteinase inhibitor. Abametapir inhibits louse metalloproteinases required for egg development and hatching, so ova exposed to it fail to produce viable nymphs.
Yes, Abametapir is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.
References & Data Sources
- ChEMBL — European Bioinformatics Institute (EBI). CHEMBL2205807. Open-access bioactivity database.
- PubChem — National Center for Biotechnology Information (NCBI). CID 15664. Chemical information database.
Data aggregated from publicly available pharmacological databases. Last updated 2026-08-20.
Embed This Widget
Add the script tag and a data attribute to embed this widget.
<script src="https://cdn.jsdelivr.net/npm/drugfyi-embed@1/dist/embed.min.js" defer></script>
<div data-drugfyi="drug" data-slug="abametapir"></div>
Embed via iframe for maximum compatibility.
<iframe src="https://drugfyi.com/iframe/drug/abametapir/" width="420" height="400" frameborder="0" style="border:0;border-radius:10px;max-width:100%" loading="lazy"></iframe>
Paste this URL in WordPress, Medium, or any oEmbed-compatible platform.
https://drugfyi.com/drug/abametapir/
Add a dynamic SVG badge to your README or docs.
[](https://drugfyi.com/drug/abametapir/)
Use the native HTML custom element.
<script src="https://cdn.jsdelivr.net/npm/drugfyi-embed@1/dist/embed.min.js" defer></script>
<drugfyi-drug slug="abametapir"></drugfyi-drug>